Protein conjugates and fusion proteins as ocular therapeutics

•Current treatments for AMD and the need for LAD are summarized.•Key considerations for development of LAD technologies are detailed.•Currently marketed products that could or do utilize LAD approaches are reviewed.•Emergent LAD technologies for current and future therapies are considered. Long-acti...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Drug discovery today 2019-08, Vol.24 (8), p.1440-1445
Hauptverfasser:	Mehta, Shrenik C., Kelley, Robert F., Tesar, Devin B.
Format:	Artikel
Sprache:	eng
Schlagworte:	Delayed-Action Preparations - therapeutic use Drug Delivery Systems - methods Eye - drug effects Humans Macular Degeneration - drug therapy Ophthalmic Solutions - therapeutic use Proteins - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!